Received Apr 17, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 1 | — | — |
she had Covid; she had Covid; The initial case was missing the following minimum criteria: Unspecified product. Upon receipt of follow-up information on 09Apr2025, this case now contains all required information to be considered valid. This is a spontaneous report received from a Consumer or other non HCP, Program ID. A 69-year-old female patient received BNT162b2 omicron (kp.2) (COMIRNATY (2024-2025 FORMULA)), on 02Mar2025 as dose 1, single (Batch/Lot number: unknown) at the age of 69 years for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Primary Immunization series complete; unknown manufacturer), for COVID-19 immunisation, reaction(s): "No adverse effect". The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 15Mar2025, outcome "recovering" and all described as "she had Covid". Therapeutic measures were taken as a result of covid-19. Clinical details: the patient had a letter from Pfizer due to a reaction from a Covid Vaccine. She got a reaction to Covid Vaccine in Mar2025; she had on the 2nd, her last one. She's had everyone, which she was ok. And then, two weeks after that, she had Covid. The patient stated she is doing better. She was taking Paxlovid. It got rid of all her symptoms, its like a heavy duty drug. She's fully vaxxed too. She's just glad the Paxlovid worked for her right away. The information on the batch/lot number for BNT162b2 omicron (kp.2) will be requested and submitted if and when received.